This email address is being protected from spambots. You need JavaScript enabled to view it.

  • Home
  • The network
  • Contributing sites

Contributing sites

map gihsn home


Implementing Partners

partners ivorycoast

National Institute of Public Hygien (INHP), Côte d’Ivoire (Ivory Coast)

The national institute is a public health institution whose mission is the control of infectious diseases. As such, it includes an epidemiological surveillance unit that conducts research on influenza.

Daouda COULIBALY, Head of the Epidemiological Surveillance Unit

• University hospital of Treichville
• University hospital of Bouaké
• General hospital of Agnibilekro
• Yopougon Attié hospital

partners southafrica

Respiratory and Meningeal Pathogens Research Unit (South Africa)

RMPRU is a research Unit focused on the epidemiology, transmission, prevention and diagnosis of vaccine preventable diseases. RMPRU forms part of and is administered by the Wits Health Consortium, a wholly owned subsidiary of the University of the Witwatersrand.

RMPRU was established in 1997, with an original research mandate to investigate pneumococcal diseases at the molecular, epidemiological, clinical and pharmacological levels. Over time, the Unit has evolved to include investigating the clinical and molecular epidemiology of other bacteria and respiratory viruses that are associated with pneumonia and meningitis. Also, the Unit has established itself to be a premier clinical trial facility for vaccine and training platforms for post-graduate students.

The Unit has undertaken pivotal studies on pneumococcal conjugate vaccine, which have helped inform the utilisation of these vaccines in low-to-middle income countries. Also, the pneumococcal vaccine studies have helped inform the interaction of pneumococcus in relation to respiratory viruses and tuberculosis associated acute community acquired pneumonia. More recently, the Unit has further evolved to focus specifically on the epidemiology and prevention of infections during the neonatal period, including programs aimed at vaccinating pregnant women to confer passive immunity and protect infants during their first few months of life. These include studies on the influenza vaccines, GBS conjugate vaccine, pertussis vaccine and RSV vaccines.

• Marta Nunes
• Shabir Madhi

Chris Hani Baragwanath Academic Hospital, Soweto, South Africa

partners india

Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Department of Internal and Pulmonary Medicine (India)

The SKIMS is engaged to provide high quality patient care, academic courses and need-based biomedical research to provide better patient care.

The institute has been one of the sites of the CDC,USA sponsored Multisite Surveillance for Influenza across India that has documented the patterns of influenza circulation in India.

Parvaiz A KOUL

Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar

partners china

Fudan University (China)

Fudan University is a comprehensive research university in China. As one of the first participants in the 211 and 985 projects.Fudan has 28 schools and 11 affiliated hospitals.


Suzhou University Affiliated Children’s Hospital

partners china2

University of Hong Kong & Chinese Centre for Disease Control and Prevention (China)

Chinese Center for Disease Control and Prevention (China CDC) is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of service.

China CDC is committed to strengthen research on strategies and measures for disease control and prevention; organizes and implements control and prevention plans for different kinds of diseases; carries out public health management for food safety, occupational health, health related product safety, radiation health, environmental health, health care for women and children, among others; conducts applied scientific research; provides technical guidance, staff training and quality control for disease control and prevention and public health services throughout the country; acts as national working group for diseases prevention, emergency relief, and construction of public health information systems.

• Yu Hongjie , Director of the Division of Infectious Disease
• Ben Cowling

• Changping District Hospital, Changping, Beijing
• The First Hospital of Huairou, Huairou, Beijing
• Daxing District Hospital, Daxing, Beijing
• Miyun County Hospital, Miyun, Beijing
• Liangxiang Hospital, Fangshan, Beijing

partners russia

Ivanovsky Institute of Virology FSBI “Federal Research Center of Microbiology and Epidemiology named after N.F. Gamaleya”, Ministry of Healthcare of the Russian Federation, WHO National Influenza Cent (Russia)

D.I. Ivanovsky Institute of Virology is one of the first-rate research organizations in the field of ecology, epidemiology, molecular biology, and molecular virology. Its mission is fundamental researching of virology, development and improvement of diagnostic methods and assessment of new antivirals against highly infectious and social diseases. Institute has been involved in influenza surveillance since 1959 both in Russia (USSR) and WHO. Since 2014 Institute had became a part of FSBI “N.F. Gamaleya FRCEM”.

Web site (in Russian)

Elena BURTSEVA, Head of Influenza Etiology and Epidemiology laboratory

• Clinical Hospital for Infectious Diseases n°1 (CHID), Moscow
• Hospital specializes on virus infectious diseases mainly, which are caused by influenza and non-influenza respiratory viruses, enteroviruses, hepatitis B and C, rotavirus, AIDS and etc. Hospital has the wards for pregnants and beds in intensive unit care (IUC).

partners stpetersburg

Research Institute of Influenza, Ministry of Healthcare of the Russian Federation, WHO recognized National Influenza Centre (Saint Petersburg) (Russia)

RII is a leading institution in the field of influenza and ARI surveillance in Russia.

RII incorporates Federal Influenza and ARI Centre and WHO National Influenza Centre, successfully operating both on the national and global levels as an integral part of WHO global influenza surveillance and response system.


• Clinical Infectious Diseases Hospital, Saint Petersburg
• Children's Infectious Multidisciplinary Hospital #5, Saint Petersburg
• Children's Multidisciplinary Hospital #4, Saint Petersburg

partners turkey

Turkish Society of Internal Medicine (Turkey)

Turkish Society of Internal Medicine has a mission to be leader in the training and continuing medical education of internal medicine specialists and subspecialists; and in the delivery of high quality patient care. One of the goals of the Society is to support scientific research projects in the field of internal medicine and to mediate a respectful relationship between the Society and the public, the academia and the industry. Adult Vaccination is one of the major domains that the Society invests in. ‘Adults, let’s go for vaccination’ is a trademarked slogan of the Society. Turkish Society of Internal Medicine is a member of the European Federation of Internal Medicine and takes the lead in the ADVICE-Adult Vaccination Campaign in Europe- Working Group.

• Serhat Unal: Principal Investigator
• Mine Durusu Tanriover: Project Coordinator

• Hacettepe University Adult Hospital, Ankara
• Hacettepe University, IhsanDogramaci Children's Hospital, Ankara
• Gazi University Faculty of MedicineHospital, Ankara
• Ankara University Faculty of Medicine, Children’s Hospital, Ankara
• Ankara Research and Training Hospital
• Ankara University Faculty of Medicine, Ibn-iSina Hospital

partners mexico

Mexico National Institutes of Health and High Speciality Hospitals Surveillance Network (Mexico)

The Ministry of Health Coordination Center of the National Institutes of Health and High Speciality Hospital (CCINSHAE)'s mission is to promote the highest level of scientific knowledge and to develop, maintain, and renew scientific human and physical resources that will ensure the Nation's capability to prevent disease, enhance health and reduce illness and disability.

The Mexico National Institutes of Health and High Specialty Hospitals Surveillance Network integrate 12 National Health Institutions and Hospitals to ensure a wide geographic representation of the north, central and south areas of the country. Its purpose is the timely identification and estimation of the incidence of severe illness (hospitalization) and the description of the clinical characteristics caused by influenza and other respiratory viruses, as well as new and emerging infectious treats to ultimately protect and improve the health of the individual and the allocation of economic resources.

Dr Guillermo M. Ruiz Palacios, MD, FIDSA, Director National Institutes of Health and High Speciality Hospitals, Ministry of Health, Mexico

• Instituto Nacional de Ciencias médicas y Nutrición Salvador Zubirán
• Instituto Nacional de Enfermedades Respiratorias (INER)
• Instituto Nacional de pediatría (INP)
• Hospital Infantil de México (HIM)
• Hospital General Dr. Manuel Gea González
• Hospital Central Dr. Ignacio Morones Prieto (San Luis Potosí)

partners czechrep

National Institute of Public Health (Czech Republic)

The National Institute of Public Health in Prague (Praha) is a health care establishment for basic preventive disciplines - hygiene, epidemiology, microbiology and occupational medicine. It's main tasks are health promotion and protection, disease prevention and follow-up of environmental impact on the health status of the population.

Jan Kyncl, Head of the Department of Infectious diseases Epidemiology

Hospital Na Bulovce, Praha

partners spain


Collaborative center:
Fundación para el Fomento de la Investigación Sanitaria y Biomedica de la Comunitat Valenciana.

FISABIO is a non-profit scientific institution, whose primary purpose is to encourage, promote and develop technical scientific investigations, health and biomedical research in Valencia. FISABIO serves more than 1,500 health professionals from the Valencia health network; specialists working in research and clinical trials managed through FISABIO.

Joan Puig-Barberà, Senior Investigator, Vaccine Research Department

• Hospital General, Castellòn
• Hospital La Fe, Valencia
• Hospital Dr Peset, Valencia
• Hospital General, Alicante

partners peru

Tropical Medicine Institute Daniel A. Carrion, San Marcos University, Lima – Peru and Centro de Investigaciones Tecnológicas, Biomédica y Medioambientales CITBM (Peru)

The Tropical Medicine Institute Daniel Carrion´s mision is to promote a highest level of scientific knolewdge in Tropical Infectious Diseases to contribute in the health care of the peruvian population. This Tropical Institute (IMT DAC in Spanish)works closely with the CITBM under a collaborative agreementincluding associate business and international research activities.

CITBM is the first Center of Excellence in Peru dedicated to the integration of science, development and technological innovation. CITBM is collaborating in multiple national and multinational biomedical, technology and innovation projects, including the development of rapid diagnostic tests and vaccines for infectious tropical diseases as malaria, leptospirosis, leishmaniasis and meningeal tuberculosis. Additionally, it leads the international consortium MDRTBNet (aERANet Lac initiative), with reference institutes of tuberculosis in Germany, Spain, France, Brazil and Italy.

Victor Alberto Laguna-Torres. MTMH. PhD Infectious diseases physician. Principal Investigator

• Hospital Nacional 2 de Mayo, Ministerio de Salud del Perú, Lima Perú
• Clínica Internacional, Lima Perú
• Hospital San Rosa, Ministerio de Salud, Piura, Perú

partners tunisia

L’Institut Pasteur de Tunis (Tunisia)

The Institut Pasteur de Tunis (IPT) is a public health research institution under the guardianship of the Tunisian Ministry of Health. It is mandated to carry out all inquiries, missions, analyses and research activities pertaining to human and animal health. IPT produces vaccines and sera for the local need. It contributes to higher education at both the national and regional level and is officially affiliated with the University of Tunis El Manar. IPT is internationally well established and collaborates with several foreign scientific institutions. The Institute is also member of the Institut Pasteur International Network, which consists of 32 institutes throughout the world.

Pr Hechmi Louzir, the General Director

• Institut Pasteur de Tunis. (Pr Hechmi Louzir, and me (Wissem Zid))
• National Influenza Center (NIC), Charles Nicolle Hospital, Tunis, Tunisia. (Pr Amine Slim)
• Abderrahman Mami Hospital, Ariana, Tunisia. (Pr Jalila Ben Khalil)
• Academic Hospital Hedi Chaker of Sfax, Sfax, Tunisia. (Pr Mounir Ben Jemaa)

partners romania

The National Institute for Infectious Diseases “Prof. Dr. Matei Bals” (Romania)

The National Institute for Infectious Diseases “Prof. Dr. Matei Bals” is the excellence center in Romania for prevention, management and research in area of infectious diseases. As a research center, the hospital has extensive experience in conducting clinical trials in the field of infectious diseases having a dedicated and accredited (FDA) clinical trials center. Vaccine trials were routinely conducted in National Institute of Infectious Diseases “Prof. Dr. Matei Bals” Bucharest (flu, pneumococcal)Severe influenza cases, both in adult and pediatric population are managed in the Institute.

The Institute is also part in the national influenza surveillance system (Romania has a national sentinel type surveillance system for influenza).A dedicated hospital epidemiology unit contributes to the national influenza surveillance program.

• Head of Institution: Prof. Dr. Adrian Streinu-Cercel
• Dr. Anca Cristina Draganescu
• Assoc. Prof. Dr. Daniela Pitigoi

National Institute for Infectious Diseases “Prof. Dr. Matei Bals” Bucharest


If you are interested in the network,
please contact us:

This email address is being protected from spambots. You need JavaScript enabled to view it.